Calian Technologies Ltd (CGY)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 83.19 |
|---|---|
| 52-week range | 44.89 – 95.50 |
| Return, 1 month / 3 months | +0.5% / +3.1% |
| Return, 1 year / 3 years | +68.8% / +79.8% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 41.8% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 3.46M CAD |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Calian Technologies, now known as Calian Group, is a Canadian services company based in Ottawa. It provides health services, training and simulation, and engineering and information technology services to government, defence and commercial customers. Its work includes supporting military and public-sector clients with specialised staffing, medical services and technical systems, alongside communications and security-related projects for organisations in Canada and abroad.
Calian Technologies Ltd trades under the code CGY on the Toronto Stock Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Calian Technologies Ltd (CGY) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 83.19 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 193 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 68.8% and over the last three months it rose 3.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.1% | ||
| From 52-week high | -9.7% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.1% | ||
| 6-month return | 20.3% | ||
| 12-month return, skipping the last month | 67.9% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.46M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | +0.5% |
| 3 months | +3.1% |
| 6 months | +20.3% |
| 1 year | +68.8% |
| 3 years | +79.8% |
| 5 years | +47.3% |
Signals
| 50-day / 200-day average | 80.77 / 76.99 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Aug 2026 | CAD 0.2800 |
| 27 May 2026 | CAD 0.2800 |
| 25 Feb 2026 | CAD 0.2800 |
| 9 Dec 2025 | CAD 0.2800 |
| 26 Aug 2025 | CAD 0.2800 |
| 27 May 2025 | CAD 0.2800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.